Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Taisho discloses promoters of NGF production

Feb. 27, 1997

Pfizer licenses potential stroke therapy

Feb. 26, 1997

Melatonin agonists from Takeda

Feb. 26, 1997

5-HT2C antagonists from Roche

Feb. 26, 1997

MS&D discloses tachykinin antagonists

Feb. 26, 1997

Watson's analgesic receives FDA approval

Feb. 25, 1997

Novo Nordisk prepares compounds with high affinity for 5-HT2C receptors

Feb. 25, 1997

Acorda and Elan to collaborate on spinal cord injury treatment

Feb. 24, 1997

Licenses offered for vasospasm therapy

Feb. 24, 1997

NIH seeks licensees for antispasmodic immunotoxin

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...